(A) In vitro translation (IVT) of Sec22 or Sec22 lacking the transmembrane domain (Sec22Delta;TMD) in the presence of ³⁵S-labeled methionine in GET3 or GET3FLAG extracts. Following anti-FLAG immunoprecipitation (IP) and 3× FLAG peptide elution as shown in the accompanying schematic, 3% of total (T) and 30% of elution (E) were resolved by SDS-PAGE and analyzed by autoradiography. Dashed lines in all the figures signify that the data came from the same gel.
(B and C) In vitro translation (IVT) of Sec22 in the indicated extracts was followed by anti-FLAG immunoprecipitation (IP) and 3× FLAG peptide elution. Samples were prepared and analyzed by autoradiography and immunoblotting (IB) as in (A).
(D) In vitro translation (IVT) of Sec22 in GET4FLAG Δget3 extract was followed by anti-FLAG immunoprecipitation (IP) and elution with recombinant Get3 (0.4 μg/μl) for 20 min at room temperature or mock treatment, as shown in the accompanying schematic. Following centrifugation, the eluted material was resolved by SDS-PAGE and analyzed by autoradiography. Elution efficiency is defined as the percentage of immobilized Sec22 input (determined by elution with SDS-PAGE loading buffer) that was eluted by Get3.
(E) Get3 elution from (D) was split and incubated with wild-type (WT) or Δget1/2 microsomes for 30 min at room temperature or mock treated. Samples were resolved by SDS-PAGE and analyzed by autoradiography. The positions of Sec22 and glycosylated Sec22 (gSec22) are indicated. Sec22 contains a C-terminal Opsin tag with an N-glycan acceptor site that facilitates detection of correctly inserted Sec22, as shown in the accompanying schematic. Insertion efficiency is defined as the percentage of total Sec22 that is glycosylated. Note that some Sec22 may be correctly inserted but not glycosylated.

(A) Schematic of the three protein domains of Sgt2. The bracketed regions indicate the span of the indicated Sgt2 truncations. Shown below is the Clustal W2 amino acid sequence alignment of the C-terminal domains of Sgt2 homologs from Saccharomyces cerevisiae (NP_014649.1), Homo sapiens (NP_003012.1), Caenorhabditis elegans (NP_494893.1), and Drosophila melanogaster (NP_609842.1). ESPript 2.0 was used to highlight identical (white in color, boxed with red), well-conserved (red in color, boxed in white), and methionine residues (shaded blue). Note that the percent of methionines in the C-terminal domain of S. cerevisiae Sgt2 (residues 208 through 346) is 7.2%, compared to an average of 7.7% for the other three Sgt2 C-terminal domains. The average percent of methionines in the M domain of SRP homologs (see Figure 5 in Keenan et al., 1998) is 2.3%.
(B) In vitro translation (IVT) of Sec22 in the indicated extracts followed by anti-FLAG immunoprecipitation (IP) and 3× FLAG peptide elution. Ten percent of the IP input (T) and 20% of 3× FLAG peptide elution (E) were resolved by SDS-PAGE and analyzed by autoradiography and immunoblotting (IB).
(C) Cytosolic lysates (T) from the indicated E. coli strains were immunoprecipitated (IP) with Ni-NTA resin. Following washing, the resin was eluted with imidazole (E). Eluted proteins were resolved by SDS-PAGE and visualized by immunoblotting (IB), as indicated.

(A) In vitro translation (IVT) of Sec22 in SGT2FLAG Δget3/5 extract followed by anti-FLAG immunoprecipitation (IP) and 3× FLAG peptide elution. Elution was split and incubated for 20 min at room temperature with Get proteins (Get3 at 35 ng/μl and Get4-Get5 at 70 ng/μl) or mock treated. This was followed by incubation for 20 min at room temperature with GET1/2 or Δget1/2 microsomes, as indicated. To minimize any potential microsome contamination by cytosolic Sgt2, Get3, and Get5, GET1/2 microsomes were prepared from the Δsgt2&; Delta get3/5 strain. The positions of Sec22 and glycosylated Sec22 (gSec22) are indicated (see Figure 1E).
(B) In vitro translation (IVT) of Sec22 in SGT2FLAG Δget3/5 extract was followed by anti-FLAG immunoprecipitation (IP) and elution with the indicated Get proteins (all at 64 ng/μl) for 20 min at room temperature or mock treatment, as shown in the accompanying schematic. Following centrifugation, elutions were collected, the resin washed, and eluted again, but this time with gel loading buffer (resin after elution). The elutions were resolved by SDS-PAGE and analyzed by autoradiography. The data are separately boxed on the left and right to signify that they came from experiments performed on different days.
(C and D) In vitro translation (IVT) of the indicated TA proteins in SGT2FLAG Δget3/5 extract was followed by anti-FLAG immunoprecipitation (IP) and elution with the indicated Get proteins for 20 min at room temperature. Samples were prepared and analyzed by autoradiography as in (B).

See Discussion for details.

(A) Cytosolic lysates from the indicated FLAG-tagged strains were immunoprecipitated (IP) with anti-FLAG resin. Following washing, the resin was eluted with 3× FLAG peptide. Eluted proteins were resolved by SDS-PAGE and visualized by Coomassie blue staining. Protein identities were established by mass spectrometry analysis (Figure S2A). Note that the Get5FLAG band from the Δget4 preparation is difficult to see because of partial proteolysis (Figure S2B).
(B) Schematic showing the subunit organization of the affinity-purified Get4/5FLAG cytosolic complex. The presence of multiple acidic residues in the C-terminal tail of Ybr137w suggests that like Hsp104 and Hsp70, it interacts directly with the TPR domain of Sgt2. The schematic is not intended to specify the copy number of each component in the complex.
(C and D) In vitro translation (IVT) of Sec22 or Sec22ΔTMD in the indicated extracts was followed by anti-FLAG immunoprecipitation (IP) and 3× FLAG peptide elution. Samples were prepared and analyzed by autoradiography and immunoblotting (IB) as in Figure 1.
(E) Cytosolic lysates from the indicated FLAG-tagged strains were immunoprecipitated (IP) with anti-FLAG resin. Following washing, the resin was eluted with 3× FLAG peptide. Eluted proteins were resolved by SDS-PAGE and visualized by Coomassie blue staining. Protein identities were established by mass spectrometry analysis. * indicates the position of a protein fragment derived from Sgt2.

(A) In vitro translation (IVT) of Fis1 or (4L)Fis1 in WT extract was followed by incubation with either WT or Δget1/2 microsomes for 30 min at room temperature. A C-terminal Opsin tag with an N-glycan acceptor site was used to monitor insertion (see Figure 1E). Samples were resolved by SDS-PAGE and analyzed by autoradiography (shown is a representative analysis). The positions of Fis1/(4L)Fis1 and glycosylated Fis1/(4L)Fis1 (gFis1/g(4L)Fis1) are indicated. Shown graphically are the average and standard deviation (three independent experiments) of the percentage of Fis1 and (4L)Fis1 inserted. Also shown highlighted in red are the four leucine substitutions in the (4L)Fis1 transmembrane domain (TMD) sequence.
(B) The indicated TA proteins were in vitro translated to comparable final concentrations in SGT2FLAG Δget3/5 extract (data not shown). Following anti-FLAG immunoprecipitation and 3× FLAG peptide elution, total (T) and eluted (E) samples were resolved by SDS-PAGE and analyzed by autoradiography (shown is a representative analysis) and immunoblotting with anti-FLAG (data not shown). Shown graphically are the average and standard deviation (three independent experiments) of each TA protein’s coimmunoprecipitation (coIP) efficiency with Sgt2.
(C and D) In vitro translation (IVT) of the indicated TA proteins in the indicated extracts was followed by anti-FLAG immunoprecipitation (IP) and 3× FLAG peptide elution. Samples were prepared and analyzed by autoradiography and immunoblotting (IB) as in Figure 1.

(A) In vitro translation (IVT) of Sec22 in SGT2FLAG Δget3/5 extract was followed by anti-FLAG immunoprecipitation (IP) and elution at different concentrations of Get3 in either the presence or the absence of Get4-Get5 for 20 min at room temperature. Shown are the average and standard deviation (two independent experiments) of percentage Sec22 eluted at different Get3 concentrations (starting at 8 ng/μl). Note that the data for Get3 concentrations after the axis break were not used in the curve fitting and that the background elution following mock treatment is ~4%. A separate hyperbolic fitting (which included the background elution and elution data at all the Get3 concentrations; see Experimental Procedures) yielded a half-maximal Get3 concentration of 0.23 μg/μl (without Get4/5) and 0.0092 μg/μl (with Get4/5).
(B) Anti-FLAG resin preimmobilized with Get3FLAG or empty resin was incubated with the indicated recombinant proteins and eluted with 3× FLAG peptide, as shown in the accompanying schematic. Input (I) and elutions (E) were resolved by SDS-PAGE and visualized by SYPRO Ruby staining.
(C) In vitro translation (IVT) of Sec22 in SGT2FLAG Δget3/5 extract was followed by anti-FLAG immunoprecipitation (IP) and elution at different concentrations of free Get5 in the presence of Get3 and preformed Get4-Get5 complex. Samples were prepared and analyzed as in Figure 5B. Shown are the average and standard deviation (two independent experiments) of percentage Sec22 eluted at different concentrations of free Get5. Also shown is a schematic of the sequestration of Sgt2 and Get3 into separate complexes in the presence of excess Get5.
(D) In vitro translation (IVT) of Sec22 in SGT2FLAG Δget3/5 extract was followed by anti-FLAG immunoprecipitation (IP) and elution with the indicated Get proteins. Notably, elution was carried out at 4°C to slow down the kinetics of elution (data not shown) and allow enough time for sample processing. Samples were prepared and analyzed as in Figure 5B. Shown are the average and standard deviation (two independent experiments) of the percentage Sec22 eluted at different times following the addition of Get proteins to resin-immobilized Sgt2. Note that data at time points after the axis break were not used in the curve fitting.